Want to join the conversation?
$STJ, a medical devices company, reported lower 1Q16 results, hurt by higher expenses. $STJ said net income fell 63% to $95MM, or $0.33 per share compared to $262MM or $0.91 per share a year ago. Revenue rose 7.6% to $1.448Bil. Excluding items, $STJ earned $0.90 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?